Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Vanda Pharmaceuticals Inc (NASDAQ: VNDA) was $4.63 for the day, up 1.76% from the previous closing price of $4.55. In other words, the price has increased by $1.76 from its previous closing price. On the day, 0.72 million shares were traded. VNDA stock price reached its highest trading level at $4.67 during the session, while it also had its lowest trading level at $4.54.
Ratios:
Our analysis of VNDA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 4.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 31, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On July 11, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
Jefferies Downgraded its Buy to Hold on February 25, 2022, whereas the target price for the stock was revised from $24 to $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 14 ’24 when Mitchell Stephen Ray sold 5,000 shares for $5.17 per share. The transaction valued at 25,863 led to the insider holds 44,857 shares of the business.
Mitchell Stephen Ray bought 5,000 shares of VNDA for $27,000 on Nov 14 ’24. On Jul 29 ’24, another insider, Moran Kevin Patrick, who serves as the SVP, CFO & Treasurer of the company, sold 2,251 shares for $5.92 each. As a result, the insider received 13,327 and left with 228,763 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VNDA now has a Market Capitalization of 269966496 and an Enterprise Value of -103018944. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.41 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at -0.54 whereas that against EBITDA is 3.416.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.46. The 50-Day Moving Average of the stock is -4.37%, while the 200-Day Moving Average is calculated to be -7.78%.
Shares Statistics:
VNDA traded an average of 676.05K shares per day over the past three months and 817500 shares per day over the past ten days. A total of 58.31M shares are outstanding, with a floating share count of 55.22M. Insiders hold about 5.30% of the company’s shares, while institutions hold 76.72% stake in the company. Shares short for VNDA as of 1732838400 were 3094619 with a Short Ratio of 4.58, compared to 1730332800 on 3740095. Therefore, it implies a Short% of Shares Outstanding of 3094619 and a Short% of Float of 6.419999999999999.
